RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab. - Wikidata - wikimedia - TriplyDB

RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab.

RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab.

http://www.wikidata.org/entity/Q34331751

about

Radiotherapy and "new" drugs-new side effects?IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial.Adenoid cystic carcinoma of head and neck: apropos of a case.Cetuximab and platinum-based chemoradio- or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial.Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response.Tumour response following high-dose intratumoural application of Viscum album on a patient with adenoid cystic carcinoma.A feasibility and safety study of concurrent chemotherapy based on genetic testing in patients with high-risk salivary gland tumors: Preliminary results.

P2860

Q26861498-4031FDF8-473F-421B-A344-0D81AACE5365 Q34253809-B53B2732-1607-4AA5-8D3D-B4FCA8F27539 Q35976268-B26FEC2B-2985-452C-89F6-AA4F85B5EFB5 Q37185867-F4D6FB96-336A-409E-A14E-58A96B99F634 Q39322631-BDA67534-B228-4334-95BA-E5F2DA06241C Q42265007-DC80F1C3-EC5E-4B06-B6A9-FE23F1063027 Q55129591-7EF998B2-767C-4433-8BBB-1CD450E61CF2

P2860

RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab.

http://www.wikidata.org/entity/Q34331751

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

RadioImmunotherapy for adenoid ...... ined treatment with cetuximab.

@ast

RadioImmunotherapy for adenoid ...... ined treatment with cetuximab.

@en

RadioImmunotherapy for adenoid ...... ined treatment with cetuximab.

@nl

type

label

RadioImmunotherapy for adenoid ...... ined treatment with cetuximab.

@ast

RadioImmunotherapy for adenoid ...... ined treatment with cetuximab.

@en

RadioImmunotherapy for adenoid ...... ined treatment with cetuximab.

@nl

prefLabel

RadioImmunotherapy for adenoid ...... ined treatment with cetuximab.

@ast

RadioImmunotherapy for adenoid ...... ined treatment with cetuximab.

@en

RadioImmunotherapy for adenoid ...... ined treatment with cetuximab.

@nl

P1433

Q34331751-9271EFC3-DB69-47F3-9407-D8D4DF77BEE0

P1476

Q34331751-A3B68FCD-E774-49C3-A2FF-935566844C3A

P2093

Q34331751-1069F6D5-BB9F-4761-BB9A-1BD3A86BD6E6

Q34331751-55AD0768-1226-44C1-98CC-C8269C28C2F1

Q34331751-61C70868-51C9-4B5E-9D56-17B413641FD8

P2860

Q34331751-09B2F72D-04C2-4552-B398-E13FC9A98FD8

Q34331751-0C5E6E2B-5C58-4850-9A40-09FD6D8A5B00

Q34331751-0ED6D814-9DBD-47FD-B603-4BC5077795CE

Q34331751-12A6D01A-DB8E-48E0-BFF2-31B1335D9CA2

Q34331751-383FA2FA-9169-44E5-BC8E-718659736F19

Q34331751-3EE8B49E-38A7-422A-BCE8-04250436603A

Q34331751-5881B176-EB9C-4A62-AEBC-F836F9D9BAF5

Q34331751-69AE33F1-399E-40FF-9BCD-4270F4C0B499

Q34331751-74212809-3E08-49A2-884A-7DA859DE49DC

Q34331751-784CE542-6E08-42AF-BE63-78F0E5D7E0F3

P2888

Q34331751-33692ADC-E8A6-4E73-BD8D-76B97B9EC1AD

P304

Q34331751-7E77697D-4F5E-45AB-87B9-A7E030BCF77E

P31

Q34331751-9B4431D8-A234-4807-950A-0A7A282CB57D

P356

Q34331751-94107FCA-AC98-4F9E-9614-D2FFA86D56E3

P478

Q34331751-ED0C7842-AE69-4EBF-8E2B-C4841C1FD2EA

P50

Q34331751-2B394130-F44A-4CF3-9540-0E21FEFD2A4A

Q34331751-33712F50-A025-42A3-A4DD-7B4143D9984F

P577

Q34331751-1BF1AEC4-877B-4AE8-B177-1765DA07A6E0

P5875

Q34331751-E98F653F-5B3B-46E3-9D6B-F9C4DE03AC18

P6179

Q34331751-4ED164D3-052A-4040-ADBF-BE76D8ECB02C

P698

Q34331751-0844E276-A3A1-41A9-99E5-F163EAF62F9B

P921

Q34331751-0331CCA1-2776-4131-AE34-748914852B72

Q34331751-5BA512F3-656B-434C-81FF-B26B1D403C54

P932

Q34331751-FF6C6799-D9F6-4B4A-84F4-FEF0A44336A1

P356

1748-717X-5-102

P1433

Radiation Oncology

P1476

RadioImmunotherapy for adenoid ...... ined treatment with cetuximab.

@en

P2093

Alexandra D Jensen

http://www.w3.org/2001/XMLSchema#string

Jürgen Krauss

http://www.w3.org/2001/XMLSchema#string

Marc W Münter

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

The role of radiotherapy in the treatment of malignant salivary gland tumors

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.

Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques.

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment

Adenoid cystic carcinoma of the major salivary glands treated with surgery and radiation.

Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approach.

Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence.

P2888

1748-717x-5-102

P304

102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1748-717X-5-102

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47675220

http://www.w3.org/2001/XMLSchema#string

P6179

1040715912

http://www.w3.org/2001/XMLSchema#string

P698

21047402

http://www.w3.org/2001/XMLSchema#string

P921

P932

2987937

http://www.w3.org/2001/XMLSchema#string